Language and speech function in children with infantile Pompe disease
- 1 June 2009
- Vol. 7 (2) , 147-156
- https://doi.org/10.3233/JPN-2009-0291
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Long-Term Enzyme Replacement Therapy for Pompe Disease With Recombinant Human Alpha-glucosidase Derived From Chinese Hamster Ovary CellsJournal of Child Neurology, 2007
- Glycogen storage disease types I and II: Treatment updatesJournal of Inherited Metabolic Disease, 2007
- Brain Development in Infantile-Onset Pompe Disease Treated by Enzyme Replacement TherapyPediatric Research, 2006
- Chinese hamster ovary cell-derived recombinant human acid α-glucosidase in infantile-onset Pompe diseaseThe Journal of Pediatrics, 2006
- A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe diseaseThe Journal of Pediatrics, 2006
- Enzyme Replacement Therapy in Classical Infantile Pompe Disease: Results of a Ten-Month Follow-Up StudyNeuropediatrics, 2005
- Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trialNeuromuscular Disorders, 2005
- The uniqueness of speech among motor systemsClinical Linguistics & Phonetics, 2004
- Pompe disease in infants and childrenThe Journal of Pediatrics, 2004